Jane Street Group, LLC Sellas Life Sciences Group, Inc. Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$4.73 - $7.18 $74,261 - $112,726	-15,700 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$5.36 - $9.53 $1,608 - $2,859	-300 Reduced 1.88%	15,700 $87,000
Q3 2021 Nov 16, 2021	SELL	$8.21 - $10.53 $205,250 - $263,250	-25,000 Reduced 60.98%	16,000 $147,000
Q2 2021 Aug 16, 2021	BUY	$7.19 - $13.71 $294,790 - $562,110	41,000 New	41,000 $455,000

4.37M

3.28M

56.3K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $24.7M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.